No Data
Atossa Therapeutics to Present Poster on (Z)-Endoxifen at AACR Special Conference in Cancer Research
Atossa Therapeutics To Present Five Abstracts For Data Regarding (Z)-Endoxifen At 2024 San Antonio Breast Cancer Symposium
Express News | Atossa Therapeutics- Got Into Open Market Sale Agreement, May Offer & Sell Shares of Our Common Stock of up to $100 Mln From Time to Time - SEC Filing
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Raises Target Price to $7
Promising Developments in Atossa Therapeutics: Advancing Endoxifen Treatments
Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update